We are live on ! Find out more
BPMC

Blueprint Medicines
BPMC

Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

138 hedge funds and large institutions have $2.53B invested in Blueprint Medicines in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 40 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 14

39% more capital invested

Capital invested by funds: $1.81B → $2.53B (+$715M)

33% more call options, than puts

Call options by funds: $3.51M | Put options by funds: $2.63M

28% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 40

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

11% more funds holding

Funds holding: 124 → 138 (+14)

0.85% more ownership

Funds ownership: 91.9% → 92.75% (+0.85%)

Holders
138
Holders Change
+14
Holders Change %
+11.29%
% of All Funds
3.44%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.2%
New
29
Increased
51
Reduced
40
Closed
14
Calls
$3.51M
Puts
$2.63M
Net Calls
+$877K
Net Calls Change
+$2.38M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$30.3M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$27.7M
3
PHS
PFM Health Sciences
California
+$18.3M
4
TCM
TimesSquare Capital Management
New York
+$16.4M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$16.4M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$31.2M
2
DCM
Driehaus Capital Management
Illinois
-$20.4M
3
RG
Redmile Group
California
-$18.6M
4
CAM
Cormorant Asset Management
Massachusetts
-$15.7M
5
Citadel Advisors
Citadel Advisors
Florida
-$15.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
51
Ameriprise
Minnesota
$3.78M +$2.9M +54,258 New
TD Asset Management
52
TD Asset Management
Ontario, Canada
$3.59M +$154K +2,886 +6%
Swiss National Bank
53
Swiss National Bank
Switzerland
$3.57M – – –
AQR Capital Management
54
AQR Capital Management
Connecticut
$3.55M -$246K -4,599 -8%
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$3.38M +$205K +3,835 +9%
First Trust Advisors
56
First Trust Advisors
Illinois
$3.34M -$520K -9,726 -17%
CS
57
Credit Suisse
Switzerland
$3.22M +$586K +10,974 +31%
SIM
58
Spark Investment Management
New York
$3.16M -$2.38M -44,500 -50%
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$3.14M +$71K +1,329 +3%
Two Sigma Advisers
60
Two Sigma Advisers
New York
$3M +$1.77M +33,100 +334%
Wells Fargo
61
Wells Fargo
California
$2.9M +$685K +12,811 +44%
NIP
62
Nicholas Investment Partners
California
$2.6M +$3.05K +57 +0.2%
FP
63
Foundry Partners
Minnesota
$2.55M -$5.72K -107 -0.3%
UBS Group
64
UBS Group
Switzerland
$2.33M +$566K +10,594 +46%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.05M -$22.7K -424 -1%
Citigroup
66
Citigroup
New York
$2.05M -$350K -6,553 -18%
NC
67
NBW Capital
Massachusetts
$2.04M -$284K -5,313 -15%
State of Wisconsin Investment Board
68
State of Wisconsin Investment Board
Wisconsin
$1.88M – – –
MLICM
69
Metropolitan Life Insurance Company (MetLife)
New York
$1.83M -$14.1K -263 -1%
AIG
70
American International Group
New York
$1.81M +$104K +1,947 +8%
Russell Investments Group
71
Russell Investments Group
United Kingdom
$1.73M -$458K -8,566 -26%
KAM
72
Kazazian Asset Management
Florida
$1.72M +$78.1K +1,462 +6%
ProShare Advisors
73
ProShare Advisors
Maryland
$1.72M +$66.5K +1,244 +5%
PIM
74
Partner Investment Management
California
$1.48M +$141K +2,630 +14%
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$1.43M – – –
1 2
3
4 5

BPMC Hedge Fund Activity: Q3 2017 in Review

138 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q3 2017, worth a combined $2.53B — up 39% from $1.81B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new BPMC positions and 14 closed out — a net gain of 15 holders — while 51 added to existing stakes and 40 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $30.3M. The largest seller was BVF Inc, cutting an estimated $31.2M.

  • 138 institutional investors held Blueprint Medicines (BPMC) as of Q3 2017, up from 124 in Q2 2017.
  • Funds reported $2.53B of Blueprint Medicines stock for Q3 2017, up 39% quarter-over-quarter.
  • 29 funds opened new Blueprint Medicines positions in Q3 2017 and 14 closed out, a net change of +15 holders.
  • The largest Blueprint Medicines buyer in Q3 2017 was Fidelity Investments, an estimated $30.3M added.
  • The largest Blueprint Medicines seller in Q3 2017 was BVF Inc, an estimated $31.2M sold.

Based on aggregated 13F filings for Q3 2017.